10-47322744-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_016204.4(GDF2):c.76C>T(p.Gln26*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,457,512 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_016204.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000406 AC: 1AN: 246330Hom.: 0 AF XY: 0.00000747 AC XY: 1AN XY: 133898
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1457512Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 724326
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pulmonary arterial hypertension Pathogenic:1
- -
Telangiectasia, hereditary hemorrhagic, type 5 Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 541541). This premature translational stop signal has been observed in individuals with severe pulmonary arterial hypertension (PMID: 26801773; Invitae). This variant is present in population databases (no rsID available, gnomAD 0.1%). This sequence change creates a premature translational stop signal (p.Gln26*) in the GDF2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GDF2 are known to be pathogenic (PMID: 26801773, 31661308, 31727138). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at